UniQure has moved quickly to cash in on its position in the biotech limelight. Within 24 hours of unveiling its $1 billion tie-up with Bristol-Myers Squibb, the gene therapy specialist had filed the paperwork for a follow-on offering that could net it upwards of $100 million (€92 million).

…read more

Source: UniQure plans $100M follow-on offering in afterglow of big-ticket Bristol deal


0 No comments